Development and clinical implementation of a digital system for risk assessments for radiation therapy.
Failure modes and effects analysis (FMEA)
Fault tree analysis (FTA)
Process throughput
Radiation therapy
Risk analysis
Risk-based quality management
Journal
Zeitschrift fur medizinische Physik
ISSN: 1876-4436
Titre abrégé: Z Med Phys
Pays: Germany
ID NLM: 100886455
Informations de publication
Date de publication:
02 Sep 2023
02 Sep 2023
Historique:
received:
15
02
2023
revised:
08
08
2023
accepted:
09
08
2023
medline:
5
9
2023
pubmed:
5
9
2023
entrez:
4
9
2023
Statut:
aheadofprint
Résumé
Before introducing new treatment techniques, an investigation of hazards due to unintentional radiation exposures is a reasonable activity for proactively increasing patient safety. As dedicated software is scarce, we developed a tool for risk assessment to design a quality management program based on best practice methods, i.e., process mapping, failure modes and effects analysis and fault tree analysis. Implemented as a web database application, a single dataset was used to describe the treatment process and its failure modes. The design of the system and dataset allowed failure modes to be represented both visually as fault trees and in a tabular form. Following the commissioning of the software for our department, previously conducted risk assessments were migrated to the new system after being fully re-assessed which revealed a shift in risk priorities. Furthermore, a weighting factor was investigated to bring risk levels of the migrated assessments into perspective. The compensation did not affect high priorities but did re-prioritize in the midrange of the ranking. We conclude that the tool is suitable to conduct multiple risk assessments and concomitantly keep track of the overall quality management activities.
Identifiants
pubmed: 37666699
pii: S0939-3889(23)00092-2
doi: 10.1016/j.zemedi.2023.08.003
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 The Author(s). Published by Elsevier GmbH.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The inventors with the Department of Radiation Oncology, Universitätsklinikum Erlangen, and IBA Dosimetry GmbH have a patent pending on some functionality of myQA® PROactive.